THYMMUNE THERAPEUTICS
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
THYMMUNE THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.thymmune.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
44 M USD
Technology used in webpage:
Organization Schema Squarespace Hosted
Similar Organizations
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Investors List
Advanced Research Projects Agency for Health
Advanced Research Projects Agency for Health investment in Grant - Thymmune Therapeutics
Pillar VC
Pillar VC investment in Seed Round - Thymmune Therapeutics
Philip Reilly
Philip Reilly investment in Seed Round - Thymmune Therapeutics
John Maraganore
John Maraganore investment in Seed Round - Thymmune Therapeutics
George Church
George Church investment in Seed Round - Thymmune Therapeutics
Arranta Bio
Arranta Bio investment in Seed Round - Thymmune Therapeutics
NYBC Ventures
NYBC Ventures investment in Seed Round - Thymmune Therapeutics
Judy Pagliuca
Judy Pagliuca investment in Seed Round - Thymmune Therapeutics
Mark Bamforth
Mark Bamforth investment in Seed Round - Thymmune Therapeutics
Official Site Inspections
http://www.thymmune.com Semrush global rank: 8.96 M Semrush visits lastest month: 445
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Thymmune Therapeutics"
Thymmune Therapeutics
At Thymmune, we are passionate about developing best-in-class treatments to improve the lives of patients with immune-mediated diseases. We have created a collaborative and inclusive …See details»
Thymmune Therapeutics - Crunchbase Company …
Organization. Thymmune Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Thymmune Therapeutics may be growing as it has recently received …See details»
Thymmune Company Profile 2024: Valuation, Funding & Investors
When was Thymmune founded? Thymmune was founded in 2019. Where is Thymmune headquartered? Thymmune is headquartered in Cambridge, MA. What is the size of …See details»
Thymmune - Pillar VC
Thymmune leverages developments in the science of differentiation of thymic cells from pluripotent stem cells to create cell therapy treatments across immunology. Categories Biotech , HealthcareSee details»
Thymmune Therapeutics Information - RocketReach
Thymmune is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The company's …See details»
Thymmune Therapeutics - LinkedIn
Thymmune Therapeutics | 4,248 followers on LinkedIn. Thymmune is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal …See details»
Thymmune Therapeutics - Company Profile & Staff Directory
Thymmune is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The company's …See details»
Thymmune Therapeutics - Overview, News & Similar companies
Sep 29, 2023 View Thymmune Therapeutics (www.thymmune.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Thymmune Therapeutics - VentureRadar
" Thymmune Therapeutics is a preclinical biotechnology company based in Cambridge, MA applying proprietary insights in thymic engineering to develop and commercialize immune cell …See details»
Thymmune Company Profile - Office Locations, Competitors
Thymmune Summary. Company Summary. Overview. Thymmune Therapeutics is a biotechnology company that provides a machine learning-enabled thymic cell engineering …See details»
Thymmune Therapeutics - Contacts, Employees, Board Members
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.See details»
Thymmune Secures $7M in Seed Financing to ... - Thymmune …
Mar 1, 2023 Thymmune is a biotechnology company developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The …See details»
Thymmune Therapeutics Company Overview, Contact Details
Cutting-edge technology Thymmune Therapeutics utilizes a machine learning-driven thymic cell engineering platform, offering a unique and advanced solution to restore immune function. …See details»
Thymmune Therapeutics - Updates, News, Events, Signals & Triggers
Mar 1, 2023 Organization. Thymmune Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Growth Insight Details. …See details»
US government backs thymus rejuvenation project with $37m
Sep 29, 2023 Two key project phases. In the initial phase of the project, researchers aim to create state-of-the-art human induced pluripotent stem thymic epithelial cells capable of …See details»
Thymmune Therapeutics Receives $37M in Funding from the …
Sep 29, 2023 Thymmune is a biotechnology company developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The …See details»
‘We want to give everyone a new thymus to reboot their immune …
Mar 14, 2024 Last year, the US government created a stir when it announced $37 million in ARPA-H project funding to restore function to the thymus – a relatively small but important …See details»
Firm - SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means …See details»
Cambridge biotech Thymmune wins $37m NIH grant for thymic …
Sep 29, 2023 Thymmune Therapeutics is undertaking the eponymous Thymus Rejuvenation project, which aims to restore damaged or non-functional thymus tissue. The thymus, a gland …See details»
Press - Thymmune Therapeutics
Mar 1, 2023 Thymmune Therapeutics Announces Manish Jain as CTO Read More. press Nina Wishnok 3/1/23 press Nina Wishnok 3/1/23. Thymmune Secures $7M in Seed Financing to …See details»